PRASOLCHEMPrasol Chemicals Ltd.
Prasol Chemicals Q2 FY27 Results: Standalone Net Profit ₹37.98 Crore on Total Income of ₹413 Crore
- Earnings
- specialty chemicals
Reviewed byRachit TripathiBlacklitt Research
Prasol Chemicals (NSE: PRASOLCHEM) reported standalone total income of ₹413.41 crore and net profit of ₹37.98 crore for the quarter ended 30 Sep 2026, it said in a filing on 02 Nov 2026. The quarter's results were approved by the board on 02 Nov 2026.
Key highlights
Standalone
The company on its own, without its subsidiaries
- Total income: ₹413.41 crore, up 38.6% YoY and down 5.0% QoQ
- Net profit: ₹37.98 crore, up 121.9% YoY and down 37.8% QoQ
- EPS: ₹6.52 basic, against ₹2.95 a year earlier and ₹10.52 in the previous quarter
- Finance costs: ₹1.71 crore, down 20.1% YoY and 5.9% QoQ
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 413.41 | 298.17 | +38.6% | 435.36 | -5.0% | |
| Revenue from operations | 412.57 | 297.65 | +38.6% | 433.65 | -4.9% |
| Other income | 0.84 | 0.52 | +62.9% | 1.71 | -50.8% |
| 37.98 | 17.11 | +121.9% | 61.02 | -37.8% | |
| Profit before tax | 49.92 | 23.24 | +114.8% | 83.56 | -40.3% |
| Finance costs | 1.71 | 2.14 | -20.1% | 1.82 | -5.9% |
| Depreciation | 6.97 | 6.19 | +12.8% | 6.61 | +5.5% |
| Tax expense | 11.95 | 6.13 | +94.9% | 22.54 | -47.0% |
| Net profit margin | 9.19% | 5.74% | +3.45 pp | 14.02% | -4.83 pp |
| EPS, basic (₹) | 6.52 | 2.95 | +121.0% | 10.52 | -38.0% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Net profit grew much faster than income. Standalone total income rose 38.6% year on year to ₹413.41 crore, while net profit rose 121.9% to ₹37.98 crore. Profit before tax rose 114.8%, and tax expense rose 94.9% to ₹11.95 crore, so the tax charge grew more slowly than profit.
Against the previous quarter, nearly every line fell: total income dropped 5.0%, profit before tax dropped 40.3% and net profit dropped 37.8%. Depreciation was the exception, rising 5.5% from ₹6.61 crore to ₹6.97 crore. The filing does not give a reason for the fall from the June quarter.
Other income is a small part of the result. At ₹0.84 crore it is 0.2% of total income and 1.7% of profit before tax of ₹49.92 crore, so the profit is almost entirely from operations. Finance costs of ₹1.71 crore are 0.4% of total income, down from ₹2.14 crore a year earlier.
Tax expense of ₹11.95 crore is 23.9% of profit before tax this quarter, against ₹6.13 crore on ₹23.24 crore a year earlier. The net profit margin was 9.19%, up from 5.74% a year earlier and down from 14.02% in the June quarter.
The company completed its Initial Public Offer in the quarter, with shares listed on NSE and BSE on 16 Sep 2026 at an issue price of ₹676 per share, aggregating to ₹500 crore. The offer for sale was ₹420 crore and the fresh issue ₹80 crore. IPO expenses of ₹2.93 crore, net of the selling shareholders' share, were adjusted against the securities premium account.
The statutory auditor, CNK & Associates LLP, issued an unmodified limited review report. The prior-year quarter was approved by the board but has not been subject to limited review or audit. The company reports one segment, Specialty Chemicals, and gives no separate segment figures.
Inference
The filing shows a final dividend paid of ₹6.96 crore in the half year ended 30 Sep 2026, against ₹1.74 crore a year earlier. The filing does not give the dividend declared for the current period or its record date.
The filing does not say how the IPO proceeds will be used. The filing also does not give a reason for the change in revenue or finance costs.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
